Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)

Clinical trial NCT07078929 · RECRUITING

Trial details

NCT number: NCT07078929
Sponsor: Chulalongkorn University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapse B Acute Lymphoblastic Leukemia Refactory Childhood Acute Lymphoblastic Leukemia

Start date: 2026-01-01
Primary completion: 2026-09-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.